Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Schoenberg currently holds 119,763 shares of UroGen Pharma Ltd. (URGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Schoenberg has been a net seller of URGN stock. They have purchased $67.4K and sold $2.3M worth of shares.
Mark Schoenberg's most recent insider trade was on Jul 9, 2026, when they sold 10,000 shares at $40.00 per share.
Mark Schoenberg serves as Executive at UroGen Pharma Ltd. (URGN). They have executed 94 insider transactions totaling $2.4M over their tenure at the company.
Mark Schoenberg holds the position of Executive at UroGen Pharma Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Mark Schoenberg has shown a selling trading pattern, with $67.4K in total purchases and $2.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Schoenberg was on Jan 20, 2023, when they sold $613.4K worth of URGN shares. This transaction involved 122,677 shares at $5.00 per share.
Mark Schoenberg currently owns 119,763 shares of UroGen Pharma Ltd. (URGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Schoenberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Schoenberg has 94 Form 4 filings on record as an insider at UroGen Pharma Ltd..
Set alerts for Mark Schoenberg and 40,000+ other insiders.